Financhill
Back

Intra-Cellular Therapies Stock Predictions

Sell
28

ITCI
Intra-Cellular Therapies

Last Price:
65.66
Seasonality Move:
-6.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Intra-Cellular Therapies Stock Forecast

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 31.6% based on the past 10 years of stock performance.
  • Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is Intra-Cellular Therapies Stock Undervalued?
    The current Intra-Cellular Therapies [ITCI] share price is $65.61. The Score for ITCI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 31.6% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell
28
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

  • Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com

52-Week Data

52-Week High:
84.89
52-Week Low:
45.50

Prediction Charts

Market Cap:
6.93B
Price in USD:
65.61
Volume:
535.44K
Beta:
1.10

Technical Analysis

SMA50:
68.82
SMA100:
68.84
SMA200:
63.00
52-Wk Change:
8.99%

Stock Predictions

  • Is Intra-Cellular Therapies stock public?
    Yes, Intra-Cellular Therapies is a publicly traded company.
  • What is the Intra-Cellular Therapies stock quote today?
    The Intra-Cellular Therapies stock price is 65.61 USD today.
  • How to buy Intra-Cellular Therapies stock online?
    You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-8 71.12 67.00 71.22 66.95
May-9 66.97 65.53 67.23 65.45
May-10 65.75 64.96 66.71 64.92
May-13 65.16 66.32 67.22 65.16
May-14 66.76 65.71 67.27 65.17
May-15 66.68 66.84 68.16 66.51
May-16 66.72 66.53 67.10 65.51
May-17 66.88 65.00 66.88 64.92
May-20 65.06 65.32 65.82 64.09
May-21 65.10 67.00 67.99 64.89
May-22 66.88 67.30 69.12 66.86
May-23 70.00 66.37 70.00 65.82
May-24 66.48 65.54 66.48 64.88
May-28 65.67 65.61 66.55 65.20

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.